Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ROJAS, BERNARDITA |
| Género | Mujer |
| Área Principal WOS | Medicine, General & Internal; Hematology; |
| Afiliación Principal | Hospital Carlos Van Buren |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, General & Internal | 2 |
| Hematology | 1 |
| Scopus | #Pub |
|---|---|
| Medicine (All) | 2 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 2 |
| Institución | # Pub |
|---|---|
| Hospital Carlos Van Buren | 3 |
| Hosp Van Buren | 1 |
| Hosp Carlos Van Buren | 1 |
| Hospital Carlos Van Buren De Valparaíso | 1 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Acute Promyelocytic Leukemia. Results Of The Chilean Protocol Lpa2000 | 2013 | 0 | artículo de investigación | Revista Médica De Chile | WoS SciELO Scopus |
| Analysis Of A Clinical Ethics Committee Activities At A General Hospital | 2022 | 0 | artículo de investigación | Revista Médica De Chile | WoS SciELO Scopus |
| Clinical Characteristics Of Chilean Adult Patients With Acute Myeloid Leukemia (Aml): Analysis Within The Framework Of The Epidemiological Registry Of Aml Of The Pethema Group | 2022 | 0 | resumen de reunión | Blood | WoS Scopus |
| Diffuse Large B Cell Lymphoma In Chile: The Impact Of Combined Chop Plus Rituximab In The Public Health System | 2022 | 1 | artículo de investigación | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| mitoxantrone | 1 |
| young-patients | 1 |
| trial | 1 |
| tretinoin | 1 |
| transretinoic acid | 1 |
| trans-retinoic acid | 1 |
| therapy | 1 |
| survival | 1 |
| risk | 1 |
| remission | 1 |
| r-chop | 1 |
| pethema | 1 |
| open-label | 1 |
| non-hodgkin-lymphoma | 1 |
| myeloid | 1 |
| multicenter | 1 |
| acute | 1 |
| medical | 1 |
| leukemia | 1 |
| experience | 1 |
| ethics committees | 1 |
| elderly-patients | 1 |
| education | 1 |
| des-lymphomes | 1 |
| daunorubicin | 1 |
| consultation | 1 |
| consolidation | 1 |
| clinical | 1 |
| classification | 1 |
| chemotherapy | 1 |
| bioethical issues | 1 |
| atra | 1 |